|
US3903297A
(en)
|
1973-11-01 |
1975-09-02 |
Upjohn Co |
Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
|
|
BR9808281A
(pt)
|
1997-03-19 |
2000-05-16 |
Basf Ag |
Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
|
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
AU2003234464B2
(en)
|
2002-05-03 |
2009-06-04 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
|
DE602004015429D1
(de)
*
|
2003-03-11 |
2008-09-11 |
Pfizer Prod Inc |
Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
|
|
PL1663978T3
(pl)
|
2003-07-23 |
2008-04-30 |
Bayer Healthcare Llc |
Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
|
|
WO2005020921A2
(en)
*
|
2003-08-29 |
2005-03-10 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
PE20070335A1
(es)
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Benzimidazoles sustituidos y metodos para su preparacion
|
|
CN101253152A
(zh)
|
2005-09-02 |
2008-08-27 |
安斯泰来制药株式会社 |
作为rock抑制剂的酰胺衍生物
|
|
ES2553390T3
(es)
|
2008-02-25 |
2015-12-09 |
Nestec S.A. |
Método para la detección de receptores truncados intracelulares
|
|
WO2010080992A1
(en)
|
2009-01-09 |
2010-07-15 |
The Trustees Of The University Of Pennsylvania |
Regulators of the interferon-alpha receptor 1 (ifnar1) chain of the interferon receptor
|
|
US8598156B2
(en)
|
2010-03-25 |
2013-12-03 |
Glaxosmithkline Llc |
Chemical compounds
|
|
WO2014170706A1
(en)
*
|
2013-04-15 |
2014-10-23 |
Università Degli Studi Di Bari |
Galloyl benzamide-based compounds as jnk modulators
|
|
WO2015056180A1
(en)
|
2013-10-15 |
2015-04-23 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Indoline derivatives as inhibitors of perk
|
|
EP3067356B1
(en)
|
2013-11-08 |
2018-07-04 |
ONO Pharmaceutical Co., Ltd. |
Pyrrolo pyrimidine derivative
|
|
JP2017507967A
(ja)
|
2014-03-11 |
2017-03-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ |
Ｐｅｒｋ阻害剤として作用する化合物
|
|
WO2016004254A1
(en)
|
2014-07-01 |
2016-01-07 |
The Regents Of The University Of California |
Combined modulation of ire1
|
|
EP3218378B1
(en)
|
2014-11-14 |
2020-01-08 |
Nerviano Medical Sciences S.r.l. |
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
|
|
GB201508747D0
(en)
|
2015-05-21 |
2015-07-01 |
Univ Edinburgh |
Compounds
|
|
BR112018001190A2
(pt)
|
2015-07-24 |
2018-09-11 |
Blueprint Medicines Corp |
composições úteis para tratar distúrbios relacionados a kit e pdfgr
|
|
EP3481831B1
(en)
|
2016-07-07 |
2023-09-06 |
Daewoong Pharmaceutical Co., Ltd. |
4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same
|
|
CN109789135A
(zh)
|
2016-07-20 |
2019-05-21 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为perk抑制剂的异喹啉衍生物
|
|
CN106748989B
(zh)
*
|
2016-11-14 |
2020-03-17 |
西安交通大学 |
一种具有抗肿瘤活性的二芳基脲类化合物及其制备方法和应用
|
|
WO2018138358A1
(en)
|
2017-01-30 |
2018-08-02 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
|
SI3612519T1
(sl)
|
2017-04-18 |
2022-04-29 |
Eli Lilly And Company |
Fenil-2-hidroksi-acetilamino-2-metil-fenilne spojine
|
|
KR102740831B1
(ko)
|
2017-11-14 |
2024-12-11 |
칠드런'즈 메디컬 센터 코포레이션 |
신규 이미다조피리미딘 화합물 및 그의 용도
|
|
EP3717459B1
(en)
*
|
2017-11-30 |
2026-01-21 |
Step Pharma S.A.S. |
Compounds
|
|
EP3492454A1
(en)
*
|
2017-11-30 |
2019-06-05 |
Step Pharma S.A.S. |
Compounds
|
|
KR102897382B1
(ko)
*
|
2018-03-26 |
2025-12-08 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
미세 잔존 암을 치료하는 방법
|
|
AU2019297428C1
(en)
|
2018-07-06 |
2023-03-23 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
|
US20220040183A1
(en)
|
2018-10-01 |
2022-02-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of inhibitors of stress granule formation for targeting the regulation of immune responses
|
|
WO2021041973A1
(en)
|
2019-08-29 |
2021-03-04 |
Hibercell, Inc. |
Perk inhibiting compounds
|
|
KR20220066290A
(ko)
|
2019-08-29 |
2022-05-24 |
히버셀, 인크. |
Perk 억제 피롤로피리미딘 화합물
|
|
WO2021041976A1
(en)
|
2019-08-29 |
2021-03-04 |
Hibercell, Inc. |
Perk inhibiting indolinyl compounds
|
|
WO2021041970A1
(en)
|
2019-08-29 |
2021-03-04 |
Hibercell, Inc. |
Perk inhibiting imidazolopyrazine compounds
|